Keyes Jeffry R. 4
4 · CNS Pharmaceuticals, Inc. · Filed Jul 16, 2021
Insider Transaction Report
Form 4
Keyes Jeffry R.
Director
Transactions
- Award
Option to purchase common stock
2021-07-15+32,000→ 178,559 totalExercise: $1.80Exp: 2031-07-15→ Common Stock (32,000 underlying)
Footnotes (2)
- [F1]The stock options set forth in this table vest on the earlier of the one-year anniversary of the date hereof or the date of the 2022 annual meeting, subject to the grantee's continued service to the Company on the vesting date.
- [F2]The stock options were issued in connection with the reporting person's Board of Director services to the Company.